2026 Grant Type 1
Here you will find a general overview of Grant Type 1 in ODIN. For full details on eligibility and expectations, consult the official ODIN Guidelines.
Large Grant for new projects:
› PARTICIPANTS: At least one academic applicant and one industry partner
› LENGTH: Up to 3 years
› BUDGET FOR EACH PROJECT: Up to DKK 6,5 Million
› TOTAL FUNDING AVAILABLE: Up to DKK 52 Million
› PURPOSE: To address complex research problems inspired by unmet clinical needs
3-Step Process and Deadlines:
STEP1. IDEAS, CHALLENGES, and/or RESOURCES are openly shared on the WorldLabs collaboration platform, and teams/projects are formed. 29 April
STEP2. ABSTRACTS are submitted for review. 16 June 15:00 CEST
STEP3. INVITED FULL-LENGTH APPLICATIONS are submitted 24 September 15:00 CEST
Anyone can post an idea, challenge, or resource. All ideas and applications are posted through WorldLabs. All templates can be found in WorldLabs under the call for which you are applying.
The templates for the 2026 GT1 Full-Length Application are also attached below for reference.
Templates related to the 2026 GT1 Full-Length Application
Templates related to the 2026 GT1 Full-Length Application
SCIENTIFIC SCOPE
ODIN focuses on research within some of the most pressing global health challenges, where outcomes hold strong innovation potential. ODIN and its funded projects are supported financially by both the Novo Nordisk Foundation (NNF) and the Lundbeck Foundation (LF).
LF-funded Scope – up to DKK 14 million
› Diseases of the central nervous system (CNS)
NNF-funded Scope – up to DKK 38 million
› Cardiovascular and Cardiometabolic diseases (CMD & CVD)
› Infectious diseases
› Regenerative medicine
› Disease-agnostic platform technologies and research tools/methods for broader healthcare applications*
*Research within platforms/tools/methods must demonstrate that the technology, tool, or method can eventually be applied to at least one of the other NNF-scope areas.
TEAM
› THE MAIN APPLICANT must be an associate or full professor from one of the 5 Danish partner universities (see information for academics)
› PARTNERS from any other university, hospital, or non-profit company are welcome, provided they can agree to the open terms and standard agreements. All public/non-profit partners may receive a portion of the project funding
› COMPANIES provide in-kind support to the project. They do not provide or receive grant funding. Each project must have at least one company partner
IMPORTANT NOTE
A standard Project Agreement is to be entered into by all project participants before starting an ODIN project. The agreement is non-negotiable, as the terms have already been defined by the founding companies and universities for the purpose of ease-of-collaboration. The Project Agreement and all other relevant documents can be found within the About ODIN page.
ABOUT ODIN
ODIN brings researchers from academia and industry together to co-create need-driven research projects that can lead to new treatments, diagnostics, tools, and technologies. We fund the strongest project ideas through competitive funding calls. Companies cannot receive ODIN funding, but participation is free of charge and gives access to academic expertise, new collaborations, and opportunities to explore early-stage research challenges.
ODIN is supported by the Novo Nordisk Foundation and the Lundbeck Foundation.
CONTACT ODIN
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 116, Bldg 1535-117.
